Tumor Heterogeneity Findings Impact Personalized Medicine Approaches
Extensive renal cancer intratumor heterogeneity identified using
Illumina sequencing may explain why biomarker development has been a hit
or miss process.
warning slight commercial slant
No comments:
Post a Comment